Art

J-GLOBAL ID：201902277815517707   Reference number：19A1861502

Preparation of Chondroitin Sulfate-Glycyl-Prednisolone Conjugate Nanogel and Its Efficacy in Rats with Ulcerative Colitis

コンドロイチン硫酸塩-グリシル-プレドニソロン抱合ナノゲルの調製と潰瘍性大腸炎ラットにおけるその有効性

Author (4)： Onishi Hiraku (Drug Delivery Research, Hoshi University) ,  Ikeuchi-Takahashi Yuri (Drug Delivery Research, Hoshi University) ,  Kawano Kumi (Drug Delivery Research, Hoshi University) ,  Hattori Yoshiyuki (Drug Delivery Research, Hoshi University)
Material： Biological and Pharmaceutical Bulletin (Web)
Volume： 42  Issue： 7  Page： 1155-1163(J-STAGE)  Publication year： 2019 
JST Material Number： U1402A  ISSN： 1347-5215  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： rat ,...
Semi thesaurus term： *グリシル-プレドニソロン ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A1861502&from=J-GLOBAL&jstjournalNo=U1402A") }}

Author keywords (12)： nanogel ,  chondroitin sulfate-glycyl-prednisolone conjugate ,  ulcerative colitis ,  particle characteristics ,  in vitro release ,  efficacy ,  nanogel ,  chondroitin sulfate-glycyl-prednisolone conjugate ,  ulcerative colitis ,  particle characteristics ,  in vitro release ,  efficacy

JST classification (2)： Basic research of drugs acting on digestive system  (GW09010Q) ,  Pharmaceutics in general  (GY01011J)

Substance index (1)： 2,4,6-Trinitrobenzenesulfonic acid

Reference (32)：

• 1) Kmieć Z. Cytokines in inflammatory bowel disease. Arch. Immunol. Ther. Exp., 46, 143-155 (1998).
• 2) Pallone F, Blanco GDV, Vavassori P, Monteleone I, Fina D, Monteleone G. Genetic and pathogenetic insights into inflammatory bowel disease. Curr. Gastroenterol. Rep., 5, 487-492 (2003).
• 3) Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, Wolfe F. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum., 58, 26-35 (2008).
• 4) Ozkul A, Yılmaz A, Akyol A, Kiylioglu N. Cerebral vasculitis as a major manifestation of rheumatoid arthritis. Acta Clin. Belg., 70, 359-363 (2015).
• 5) Kochi M, Kohagura K, Shiohira Y, Iseki K, Ohya Y. Inflammation as a risk of developing chronic kidney disease in rheumatoid arthritis. PLOS ONE, 11, e0160225 (2016).

Terms in the title (8)： コンドロイチン硫酸塩 ,  プレドニソロン ,  抱合 ,  ナノゲル ,  調製 ,  潰瘍性大腸炎 ,  ラット ,  有効性